Evaluating Inhibitor Risk Following Factor Product Switches – Results from ATHN 2
American Thrombosis and Hemostasis Network (ATHN) shared a post on LinkedIn about a recent article by Erin Cockrell et al., published in Haemophilia, adding:
“New ATHN research published in Haemophilia provides important real-world evidence on factor product switching.
The ATHN 2: Factor Switching Study found no new inhibitor development among previously treated people with hemophilia A or B following a factor product switch among participants with evaluable follow-up.
Thank you to the participants, investigators, and ATHN-affiliated sites who made this work possible.
We are especially grateful for the contributions of the late Dr. Janna Journycake, Co-PI of ATHN 2.
Janna’s scientific leadership, dedication, and vision were an important part of this work and of the foundation upon which ATHN 2 was built.
Her impact continues to be felt today, and we are honored to recognize her enduring legacy through this publication and the work that continues because of it.”
Title: Lack of Inhibitor Development in Previously Treated People With Haemophilia Switching Factor Products—Final Results of Athn 2: Factor Switching Study
Authors: Erin Cockrell, Martin Chandler, Tammuella Chrisentery-Singleton, Stacy E. Croteau, Nabil Daoud, Michael F. Guerrera, M. Nikki Hirsh, Janna Journeycake, Roshni Kulkarni, Susan U. Lattimore, Catherine McGuinn, Margaret Ragni, Michael Recht, Ulrike M. Reiss, Robert Sidonio Jr., Cliffford M. Takemoto, Michael Tarantino, Annette von Drygalski, Ellis J. Neufeld
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment